Judith de Vries-Ten Have

Judith de Vries-Ten Have

Auto-generated profile, based on publicly available information

Judith de Vries-Ten Have

Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, The Netherlands

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2020 in Nutrition Research Reviews
Verified
Journal Article
Open access
PDF file
JHJudith de Vries-Ten Have
Judith de Vries-Ten Have
AOAdedotun Owolabi
Adedotun Owolabi
JSJan Steijns
Jan Steijns
UKUrszula Kudla
Urszula Kudla
AMAlida Melse-Boonstra
Alida Melse-Boonstra
Protein is important for growth, maintenance and protection of the body. Both adequacy of protein quantity and protein quality in the diet are important to guarantee obtaining all the essential amino acids. Protein–energy malnutrition is widely present in developing countries such as Nigeria and might result in stunting and wasting. Needs for protein differ depending on age and physiological status and are higher during growth, pregnancy and lactation. The present review assessed protein quantity and quality in diets of Nigerian infants, children, adolescents, and pregnant and lactating women. Literature reviews and calculations were performed to assess adequacy of Nigerian protein intake and to examine the Nigerian diet. The digestible indispensable amino acid score was used to calculate protein quality of nine Nigerian staple foods and of a mixture of foods. The Nigerian population had mostly adequate protein intake when compared with the most recent protein recommendations by the FAO (2013) and WHO/FAO/UNU (2007). An important exception was the protein intake of adolescent girls and pregnant and lactating women. Most of the assessed Nigerian plant-based staple foods were of low protein quality and predominantly lacked the amino acid lysine. The addition of animal-source foods can bridge the protein quality gap created by predominance of plant-based foods in the Nigerian diet. The methodology of this review can be applied to other low- and middle-income countries where diets are often plant-based and lack variety, which might influence protein intake adequacy.

13 October 2023 in International Journal of Behavioral Nutrition and Physical Activity
Verified
Journal Article
Open access
PDF file
JHJudith de Vries-Ten Have
Judith de Vries-Ten Have
RWRenate M. Winkels
Renate M. Winkels
EKEllen Kampman
Ellen Kampman
LWLaura H.H. Winkens
Laura H.H. Winkens
Background: Lifestyle interventions that target dietary and/or physical activity behaviours may impact cancer-related fatigue in cancer survivors. Changing lifestyle may be especially difficult for cancer survivors suffering from cancer-related fatigue. To increase effectiveness of lifestyle interventions, behaviour change techniques (BCTs) can be applied. The aim of this review is to systematically describe which BCTs are applied in lifestyle interventions targeting cancer-related fatigue among cancer survivors who finished primary treatment. Methods: PubMed, Scopus, PsycINFO, Cochrane Library and Web of Science were searched to identify randomised controlled trials (RCTs) of dietary and/or physical activity interventions targeting cancer-related fatigue in cancer survivors. The BCT taxonomy was used to code the BCTs that were applied in those interventions. BCTs that were reported in at least 25% of effective interventions were indicated as ‘promising BCT’, but only retained this classification when these BCTs were present in less than 25% of ineffective interventions. Results: Twenty-nine RCTs were identified, of which 17 were effective in reducing cancer-related fatigue. The most frequently applied BCTs were Goal setting (behaviour), Instruction on how to perform the behaviour, Demonstration of the behaviour, Behavioural practice/rehearsal, and Credible Source. The BCT ‘Generalisation of the target behaviour’ was identified as promising. These results should be interpreted with caution as only three studies screened their participants on level of cancer-related fatigue and most studies focused only on physical activity. Furthermore, many studies did not include a measure for actual behaviour change and had no follow-up period after the intervention ended. Conclusions: There is a need for studies that screen their participants on level of cancer-related fatigue and a need for studies that focus more on dietary behaviours as a possible intervention to reduce fatigue. Also, studies should include follow-up timepoints after the interventions ends to examine long-term behaviour change. Future lifestyle interventions should describe interventions in detail to allow for easier coding of BCTs, and report on actual behaviour change following the intervention. Interventions may apply the BCT ‘Generalisation of the target behaviour’ to incorporate lifestyle behaviours in daily life. This may increase the chance that interventions will effectively reduce cancer-related fatigue.

5 January 2024 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Closed access
PDF file
JKJoann Kiebach
Joann Kiebach
JHJudith de Vries-Ten Have
Judith de Vries-Ten Have
FDFranzel van Duijnhoven
Franzel van Duijnhoven
DKDieuwertje Kok
Dieuwertje Kok
ALAnne-Sophie van Lanen
Anne-Sophie van Lanen
EWEvertine Wesselink
Evertine Wesselink
Background: Cancer-related fatigue (CRF) is a frequent symptom in colorectal cancer survivors. It is unknown to what extent anemia may contribute to CRF in colorectal cancer survivors. This study aimed to investigate the association between hematocrit, as marker for anemia, and CRF among colorectal cancer survivors from diagnosis until two years thereafter. Methods: The study population included 1,506 newly diagnosed colorectal cancer survivors at any stage of disease from a prospective cohort study. Hematocrit and CRF (EORTC QLQ-C30) were assessed at diagnosis, six months, and two years after diagnosis. Multivariable logistic regression or multivariable linear mixed models were used to assess the associations of hematocrit with CRF prevalence, or CRF severity over time, respectively. Results: A low hematocrit (levels <40% men/<36% women) was present in a third of the survivors at diagnosis and six months thereafter, and among 16% two years after diagnosis. The prevalence of CRF was 15% at diagnosis, peaked at 27% at six months, and was 14% two years after diagnosis. Hematocrit was associated with the prevalence of CRF at diagnosis [OR, 0.92; confidence interval (CI), 0.88–0.95], 6 months (OR, 0.89; 95% CI, 0.86–0.92), and 2 years (OR, 0.91; CI, 0.87–0.96) after diagnosis. Lower hematocrit was associated with higher severity of CRF over time (beta-coefficient = 1.3; CI, 1.5–1.1). Conclusions: Lower hematocrit levels were longitudinally associated with a higher prevalence and severity of CRF in colorectal cancer. Impact: Our findings emphasize the importance of long-term anemia monitoring and a potential role of anemia in CRF among colorectal cancer survivors.

1 March 2024
Verified
Other
Open access
JKJoann Kiebach
Joann Kiebach
JHJudith de Vries-Ten Have
Judith de Vries-Ten Have
FDFranzel van Duijnhoven
Franzel van Duijnhoven
DKDieuwertje Kok
Dieuwertje Kok
ALAnne-Sophie van Lanen
Anne-Sophie van Lanen
EWEvertine Wesselink
Evertine Wesselink
Sensitivity analyses on the association between hematocrit levels and severity of CRF at the different timepoints among survivors that were fatigued or anemic at least once during the study period

1 March 2024
Verified
Other
Open access
JKJoann Kiebach
Joann Kiebach
JHJudith de Vries-Ten Have
Judith de Vries-Ten Have
FDFranzel van Duijnhoven
Franzel van Duijnhoven
DKDieuwertje Kok
Dieuwertje Kok
ALAnne-Sophie van Lanen
Anne-Sophie van Lanen
EWEvertine Wesselink
Evertine Wesselink
Analyses on the association between hematocrit levels and prevalence and severity of CRF at the different timepoints stratified by tumor stage and location

1 March 2024
Verified
Other
Open access
JKJoann Kiebach
Joann Kiebach
JHJudith de Vries-Ten Have
Judith de Vries-Ten Have
FDFranzel van Duijnhoven
Franzel van Duijnhoven
DKDieuwertje Kok
Dieuwertje Kok
ALAnne-Sophie van Lanen
Anne-Sophie van Lanen
EWEvertine Wesselink
Evertine Wesselink
Background:Cancer-related fatigue (CRF) is a frequent symptom in colorectal cancer survivors. It is unknown to what extent anemia may contribute to CRF in colorectal cancer survivors. This study aimed to investigate the association between hematocrit, as marker for anemia, and CRF among colorectal cancer survivors from diagnosis until two years thereafter.Methods:The study population included 1,506 newly diagnosed colorectal cancer survivors at any stage of disease from a prospective cohort study. Hematocrit and CRF (EORTC QLQ-C30) were assessed at diagnosis, six months, and two years after diagnosis. Multivariable logistic regression or multivariable linear mixed models were used to assess the associations of hematocrit with CRF prevalence, or CRF severity over time, respectively.Results:A low hematocrit (levels <40% men/<36% women) was present in a third of the survivors at diagnosis and six months thereafter, and among 16% two years after diagnosis. The prevalence of CRF was 15% at diagnosis, peaked at 27% at six months, and was 14% two years after diagnosis. Hematocrit was associated with the prevalence of CRF at diagnosis [OR, 0.92; confidence interval (CI), 0.88–0.95], 6 months (OR, 0.89; 95% CI, 0.86–0.92), and 2 years (OR, 0.91; CI, 0.87–0.96) after diagnosis. Lower hematocrit was associated with higher severity of CRF over time (beta-coefficient = 1.3; CI, 1.5–1.1).Conclusions:Lower hematocrit levels were longitudinally associated with a higher prevalence and severity of CRF in colorectal cancer.Impact:Our findings emphasize the importance of long-term anemia monitoring and a potential role of anemia in CRF among colorectal cancer survivors.